126 related articles for article (PubMed ID: 10974382)
1. A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer.
Hayter CR; Huff-Winters C; Paszat L; Youssef YM; Shelley WE; Schulze K
Radiother Oncol; 2000 Sep; 56(3):329-33. PubMed ID: 10974382
[TBL] [Abstract][Full Text] [Related]
2. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
[TBL] [Abstract][Full Text] [Related]
4. Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial.
Borg D; Sundberg J; Brun E; Kjellén E; Petersson K; Hermansson M; Johansson J; Eberhard J; Johnsson A
Acta Oncol; 2020 Feb; 59(2):212-218. PubMed ID: 31564184
[No Abstract] [Full Text] [Related]
5. Nonsurgical management of esophageal cancer: report of a study of combined radiotherapy and chemotherapy.
Coia LR; Engstrom PF; Paul A
J Clin Oncol; 1987 Nov; 5(11):1783-90. PubMed ID: 2445931
[TBL] [Abstract][Full Text] [Related]
6. A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus.
Harney J; Goodchild K; Phillips H; Glynne-Jones R; Hoskin PJ; Saunders MI
Clin Oncol (R Coll Radiol); 2003 May; 15(3):109-14. PubMed ID: 12801046
[TBL] [Abstract][Full Text] [Related]
7. Chemoradiation therapy is effective for the palliative treatment of malignant dysphagia.
Harvey JA; Bessell JR; Beller E; Thomas J; Gotley DC; Burmeister BH; Walpole ET; Thomson DB; Martin I; Doyle L; Burmeister E; Smithers BM
Dis Esophagus; 2004; 17(3):260-5. PubMed ID: 15361102
[TBL] [Abstract][Full Text] [Related]
8. Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus.
Powell ME; Hoskin PJ; Saunders MI; Foy CJ; Dische S
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):133-6. PubMed ID: 9212014
[TBL] [Abstract][Full Text] [Related]
9. Palliative radiotherapy and chemoradiotherapy in stage IVA/B esophageal cancer patients with dysphagia.
Kawamoto T; Nihei K; Sasai K; Karasawa K
Int J Clin Oncol; 2018 Dec; 23(6):1076-1083. PubMed ID: 30066207
[TBL] [Abstract][Full Text] [Related]
10. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study.
Burmeister BH; Denham JW; O'Brien M; Jamieson GG; Gill PG; Devitt P; Yeoh E; Hamilton CS; Ackland SP; Lamb DS
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):997-1006. PubMed ID: 7607974
[TBL] [Abstract][Full Text] [Related]
11. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
Bhatt L; Tirmazy S; Sothi S
Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
[TBL] [Abstract][Full Text] [Related]
12. Management of adenocarcinoma of the esophagus with chemoradiation alone or chemoradiation followed by esophagectomy: results of sequential nonrandomized phase II studies.
Algan O; Coia LR; Keller SM; Engstrom PF; Weiner LM; Schultheiss TE; Hanks GE
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):753-61. PubMed ID: 7790262
[TBL] [Abstract][Full Text] [Related]
13. Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction.
Coia LR; Paul AR; Engstrom PF
Cancer; 1988 Feb; 61(4):643-9. PubMed ID: 3338031
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma.
Coia LR; Engstrom PF; Paul AR; Stafford PM; Hanks GE
Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):29-36. PubMed ID: 1704362
[TBL] [Abstract][Full Text] [Related]
15. Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
Sunde B; Ericson J; Kumagai K; Lundell L; Tsai JA; Lindblad M; Rouvelas I; Friesland S; Wang N; Nilsson M
Dis Esophagus; 2016 Jul; 29(5):442-7. PubMed ID: 25809837
[TBL] [Abstract][Full Text] [Related]
16. Prospective non-randomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without paclitaxel in esophageal cancer patients: long-term follow-up.
Zemanova M; Petruzelka L; Pazdro A; Kralova D; Smejkal M; Pazdrova G; Honova H
Dis Esophagus; 2010 Feb; 23(2):160-7. PubMed ID: 19515190
[TBL] [Abstract][Full Text] [Related]
17. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
19. Inoperable esophageal carcinoma: results of aggressive synchronous radiotherapy and chemotherapy. A pilot study.
John M; Flam M; Wittlinger P; Mowry PA
Am J Clin Oncol; 1987 Aug; 10(4):310-6. PubMed ID: 2441591
[TBL] [Abstract][Full Text] [Related]
20. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207).
Gaspar LE; Winter K; Kocha WI; Pinover WH; Herskovic ; Graham M; Gunderson L
Cancer J; 2001; 7(5):388-94. PubMed ID: 11693897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
